Filter posts

BIO Patient & Health Advocacy Summit Concludes Today

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health …

Lessons from “View from the Board: Responding to an Acquisition Offer”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO …

On Track for a Record Breaking 2018 – #BIF18 Opening Plenary

Despite some recent market volatility, the industry is well positioned for long-term growth and success. …

Innovation Intersecting with Investing – Welcome to the BIO Investor Forum

Today marks the 17th opening of the BIO Investor Forum—a place where emerging biotech companies, …

Investment Market Good for Deal-making at #BIF18

As we move into the final quarter of 2018, we reflect on a year with …

Digital Health Innovation to be Spotlighted at the BIO Investor Forum

Is your company trying to expand into “digiceuticals” or digital therapeutics? Are you looking to …

Heralding In A New Era of Precision Medicine

The healthcare ecosystem is experiencing an acceleration in the uptake of the precision medicine paradigm …

Biotech Leaders Talk Deal-Making and State of the Industry

A standing-room only crowd was captivated as a panel of life science and venture capital …

Scouring the Genome for Autism Insights

Tackling a family of conditions as complex as the various autism spectrum disorders (ASDs) will …

“Real Opportunity” to Boost Diversity in Biotech

The Biotechnology Innovation Organization has set a goal for its member companies to have 50% …